Epithelial mesenchymal transition traits in human breast cancer cell lines
- PMID: 18461285
- DOI: 10.1007/s10585-008-9170-6
Epithelial mesenchymal transition traits in human breast cancer cell lines
Abstract
Epithelial mesenchymal transition (EMT) has long been associated with breast cancer cell invasiveness and evidence of EMT processes in clinical samples is growing rapidly. Genome-wide transcriptional profiling of increasingly larger numbers of human breast cancer (HBC) cell lines have confirmed the existence of a subgroup of cell lines (termed Basal B/Mesenchymal) with enhanced invasive properties and a predominantly mesenchymal gene expression signature, distinct from subgroups with predominantly luminal (termed Luminal) or mixed basal/luminal (termed Basal A) features (Neve et al Cancer Cell 2006). Studies providing molecular and cellular analyses of EMT features in these cell lines are summarised, and the expression levels of EMT-associated factors in these cell lines are analysed. Recent clinical studies supporting the presence of EMT-like changes in vivo are summarised. Human breast cancer cell lines with mesenchymal properties continue to hold out the promise of directing us towards key mechanisms at play in the metastatic dissemination of breast cancer.
Similar articles
-
Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):235-52. doi: 10.1007/s10911-010-9175-z. Epub 2010 Jun 4. J Mammary Gland Biol Neoplasia. 2010. PMID: 20521089 Review.
-
A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samples.PLoS One. 2014 Feb 21;9(2):e89262. doi: 10.1371/journal.pone.0089262. eCollection 2014. PLoS One. 2014. PMID: 24586640 Free PMC article.
-
Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.J Biol Chem. 2015 Mar 13;290(11):6857-67. doi: 10.1074/jbc.M114.610915. Epub 2015 Jan 20. J Biol Chem. 2015. PMID: 25605728 Free PMC article.
-
LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer.Cancer Res. 2010 Mar 15;70(6):2296-306. doi: 10.1158/0008-5472.CAN-09-3141. Epub 2010 Mar 9. Cancer Res. 2010. PMID: 20215510 Free PMC article.
-
Epithelial-mesenchymal transition in tumor metastasis.Mol Oncol. 2017 Jan;11(1):28-39. doi: 10.1002/1878-0261.12017. Epub 2016 Dec 9. Mol Oncol. 2017. PMID: 28085222 Free PMC article. Review.
Cited by
-
Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.Cancer Cell. 2012 Dec 11;22(6):725-36. doi: 10.1016/j.ccr.2012.09.022. Epub 2012 Nov 29. Cancer Cell. 2012. PMID: 23201165 Free PMC article.
-
Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.Breast Cancer Res. 2012 May 21;14(3):R79. doi: 10.1186/bcr3192. Breast Cancer Res. 2012. PMID: 22613095 Free PMC article.
-
Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin).Cell Cycle. 2012 Nov 1;11(21):4020-32. doi: 10.4161/cc.22225. Epub 2012 Sep 19. Cell Cycle. 2012. PMID: 22992620 Free PMC article.
-
Diversity of matriptase expression level and function in breast cancer.PLoS One. 2012;7(4):e34182. doi: 10.1371/journal.pone.0034182. Epub 2012 Apr 13. PLoS One. 2012. PMID: 22514623 Free PMC article.
-
Manganese Superoxide Dismutase Expression Regulates the Switch Between an Epithelial and a Mesenchymal-Like Phenotype in Breast Carcinoma.Antioxid Redox Signal. 2016 Aug 20;25(6):283-99. doi: 10.1089/ars.2015.6524. Antioxid Redox Signal. 2016. PMID: 27400860 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical